Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
PharmChem Inc. (PCHM) had Consolidated Net Income/Loss of $0.27M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$1.58M |
|
$0.27M |
|
-- |
|
$1.58M |
|
-- |
|
$1.58M |
|
-- |
|
$1.58M |
|
$1.58M |
|
$1.58M |
|
$0.27M |
|
|
Consolidated Net Income/Loss |
$0.27M |
$1.58M |
|
$1.58M |
|
$1.58M |
|
4.62M |
|
4.62M |
|
$0.06 |
|
$0.06 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
$0.00M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
100.00% |
|
100.00% |
|
-- |
|
100.00% |
|
17.22% |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|